Impact Study of Cholera Vaccination in Endemic Areas

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

6000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-11

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to fill this essential knowledge gap by assessing the impact of oral cholera vaccine mass campaigns in 2 sites (urban and rural) in DRC, described in this protocol. The evidence generated from this project will be key to develop future strategies regarding cholera vaccine use in endemic settings, including places with higher burden in terms of cholera mortality.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence

NCT05829772

Cholera

COMPLETED

Preventative Intervention for Cholera for 7 Days

NCT05166850

Cholera Water-Related Diseases Diarrhea Infectious

RECRUITING NA

Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of Congo

NCT02928341

Cholera Diarrhea

COMPLETED NA

Mass Oral Cholera Vaccination in Zanzibar

NCT00709410

Cholera Diarrhea

COMPLETED NA

Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts

NCT02864433

Cholera Diarrhea

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The project will comprise three different components:

1. Clinical cholera surveillance to measure cholera diseases incidence in selected African hotspots targeted by vaccination.
2. Serial serological surveys to measure the prevalence of recent cholera infection (within the last 12 months).
3. Identification and follow up of individuals with positive V. cholerae shedding (symptomatic or asymptomatic) among sero-survey participants and among household members of cholera confirmed cases.

The present protocol relates to the setup of clinical surveillance and the follow up of individuals with positive V. cholerae shedding identified through clinical surveillance, in DRC.

This protocol will allow us to assess if a large vaccination campaign reaching high coverage in cholera hotspot in Africa can allow sustained control of cholera for at least two years, by fulfilling the following specific objectives:

* To measure cholera incidence rates following the mass vaccination campaign in two cholera hotspots in Africa.
* To assess the duration of shedding among vaccinated and unvaccinated individuals and the duration of viable V. cholerae in the peri-household environment.
* To measure the secondary cholera attack rates (symptomatic and asymptomatic) at household level among vaccinated and unvaccinated individuals following the identification of an index case in a given household.
* To describe the global genetic diversity of V. cholerae strains in the study areas and within households affected by cholera.
* To develop sustainable surveillance methods that could be applied in other hotspots in Africa and elsewhere aiming to monitor the impact of the cholera control program.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholera

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients presenting at the time of the study to any selected Cholera Treatment Center/Cholera Treatment Unit (CTC/CTU), matching the case definition and giving his/her consent (or assent for children 8 to 17 years old) to participate in the study will be eligible.

1. present to any selected CTC/CTU, match the case definition, participate to the clinical surveillance activity and test positive to RDT OR

Exclusion Criteria

* Patients who decline to participate will be excluded from the study.

Follow up of individuals with active cholera shedding:

\- Individuals who decline to participate will be excluded from the study, as well as households for whom the head of the household (and his or her representative) decline the participation of his/her household.

Eligible Sex

ALL

Accepts Healthy Volunteers

No